Biotech

All Articles

A nearer take a look at Tough Biotech's Fierce 15

.In this particular week's incident of "The Leading Line," our experts're diving right into Fierce B...

Lilly deals with phase 2 failing of tau-targeting med

.The confetti is still soaring from Eli Lilly's celebration celebrating the commendation of Alzheime...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of substantial management hirings, firings a...

Lykos will definitely inquire FDA to reassess its own decision adhering to being rejected of MDMA therapy for trauma

.Adhering to a poor presenting for Lykos Therapeutics' MDMA applicant for post-traumatic stress diso...

AN 2 halves roll call, quits phase 3 test after records disappoint

.AN2 Therapeutics is actually rethinking its business in response to uninspired midphase data, pledg...

Merck pays for $700M for bispecific, spying autoimmune opening as well as chance to test Amgen in cancer

.Merck &amp Co. is actually paying $700 thousand beforehand to test Amgen in a blood cancer cells ma...

Gilead pays J&ampJ $320M to exit licensing package for seladelpar

.With Gilead Sciences about to an FDA choice for its own liver ailment medication seladelpar, the bu...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks may find the business putting together outdoors tents at basecamp behind Eli Lilly ...

Entero laying off team, abandoning workplace and also stopping R&ampD

.Bed Liquidators has transformed Entero Therapies white as a slab. The creditor bought Entero to set...

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is losing hope on its own tissue variable (TF)- targeting antibody-drug conjugate after co...